Global RSV Vaccines Market Set to Soar to US$164.4 Billion by 2035 — Growing 33.6× in Just a Decade
The global market for Respiratory Syncytial Virus (RSV) vaccines is projected to surge from an estimated US$4.89 billion in 2025 to a staggering US$164.40 billion by 2035, representing an extraordinary compound annual …
Global RSV Vaccines Market Set to Soar to US$164.4 Billion by 2035 — Growing 33.6× in Just a Decade Read More